Rafeh Naqash: Looking forward to CoChairing the Developmental Therapeutics -Immunotherapy Orals at ASCO 2024

Tian Zhang, Associate Professor and Director of Clinical Research at UT Southwestern Medical Center, shared a post by Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center, on X/Twitter, adding:

”The developmental IO oral session at ASCO 2024 will be stacked with good trials! Looking forward to a stellar lineup and working with co-chair Rafeh Naqash.”

Quoting Rafeh Naqash’s post:

”Looking forward to CoChairing the Developmental Therapeutics -Immunotherapy Orals at ASCO 2024 with Tian Zhang. We have a superb line up of speakers and cutting edge IO trails at ASCO 2024.”

Source: Tian Zhang/X and Rafeh Naqash/X